1887
Surveillance Open Access
Like 0

Abstract

Background

Vaccine-derived polioviruses (VDPVs) continue to circulate internationally, causing sporadic cases and outbreaks of paralytic polio in countries certified as polio-free. In 2022, sustained detection of type 2 VDPVs was reported in environmental surveillance samples collected from London. Genetic mutations indicative of loss of attenuation of virulence were observed, consistent with community transmission events over several months.

Aim

We aimed to determine the extent of geographical spread of transmission in an area of environmental poliovirus detection.

Methods

We implemented an opportunistic, cross-sectional survey in areas where environmental surveillance indicated sustained VDPV transmission between October 2022 and April 2023. Residual stool samples taken from children < 16 years presenting to primary or secondary healthcare were examined for enteroviruses, including poliovirus. Methods for poliovirus detection recommended by the World Health Organization, including virus isolation in cell culture, PCR and molecular characterisation, were applied to residual stool material on a daily basis with real-time clinical reporting.

Results

We examined 1,251 stool samples from 1,051 children presenting to healthcare with illness over a 6-month period. A range of enteroviruses from groups A, B and C were found, but no poliovirus was detected. Documented polio vaccination coverage was high, between 95% and 98% in under 5-year-olds.

Conclusion

Poliovirus was not widespread in the area of environmental poliovirus isolation. Opportunistic poliovirus testing of residual stool samples taken from children seeking healthcare was feasible and can be implemented rapidly in areas where poliovirus circulation is suspected, although untargeted sampling may not adequately capture populations at highest risk.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.16.2500025
2025-04-24
2025-04-26
/content/10.2807/1560-7917.ES.2025.30.16.2500025
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/16/eurosurv-30-16-4.html?itemId=/content/10.2807/1560-7917.ES.2025.30.16.2500025&mimeType=html&fmt=ahah

References

  1. World Health Organization (WHO). History of polio vaccination. Geneva: WHO. [Accessed: 6 May 2024]. Available from: https://www.who.int/news-room/spotlight/history-of-vaccination/history-of-polio-vaccination
  2. World Health Organization (WHO). Standard operating procedures. Responding to a poliovirus event or outbreak. Version 4.1. Geneva: WHO; 2022. Available from: https://polioeradication.org/wp-content/uploads/2022/09/Standard-Operating-Procedures-For-Responding-to-a-Poliovirus-Event-Or-Outbreak-20220905-V4-EN.pdf
  3. Wilder-Smith A, Osman S. Public health emergencies of international concern: a historic overview. J Travel Med. 2020;27(8):taaa227. PMID: 33284964 
  4. Namageyo-Funa A, Greene SA, Henderson E, Traoré MA, Shaukat S, Bigouette JP, et al. Update on vaccine-derived poliovirus outbreaks - worldwide, January 2023-June 2024. MMWR Morb Mortal Wkly Rep. 2024;73(41):909-16.  https://doi.org/10.15585/mmwr.mm7341a1  PMID: 39418214 
  5. Böttcher S, Kreibich J, Wilton T, Saliba V, Blomqvist S, Al-Hello H, et al. Detection of circulating vaccine-derived poliovirus type 2 (cVDPV2) in wastewater samples: a wake-up call, Finland, Germany, Poland, Spain, the United Kingdom, 2024. Euro Surveill. 2025;30(3):2500037.  https://doi.org/10.2807/1560-7917.ES.2025.30.3.2500037  PMID: 39850005 
  6. Rendi-Wagner P, Kluge H. Poliovirus detections in Europe - urgent action needed to keep Europe polio-free. Euro Surveill. 2025;30(4):2500076.  https://doi.org/10.2807/1560-7917.ES.2025.30.4.2500076  PMID: 39885823 
  7. Global Polio Eradication Initiative (GPEI). Surveillance indicators. Geneva: World Health Organization. [Accessed: 6 May 2024]. Available from: https://polioeradication.org/polio-today/surveillance-indicators
  8. Klapsa D, Wilton T, Zealand A, Bujaki E, Saxentoff E, Troman C, et al. Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance. Lancet. 2022;400(10362):1531-8.  https://doi.org/10.1016/S0140-6736(22)01804-9  PMID: 36243024 
  9. Link-Gelles R, Lutterloh E, Schnabel Ruppert P, Backenson PB, St George K, Rosenberg ES, et al. Public health response to a case of paralytic poliomyelitis in an unvaccinated person and detection of poliovirus in wastewater - New York, June-August 2022. MMWR Morb Mortal Wkly Rep. 2022;71(33):1065-8.  https://doi.org/10.15585/mmwr.mm7133e2  PMID: 35980868 
  10. Zuckerman NS, Bar-Or I, Sofer D, Bucris E, Morad H, Shulman LM, et al. Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022. Euro Surveill. 2022;27(37):2200694.  https://doi.org/10.2807/1560-7917.ES.2022.27.37.2200694  PMID: 36111556 
  11. UK Health Security Agency (UKHSA). Immediate actions in response to detection of a ‘circulating’ vaccine derived polio virus type 2 (VDPV2) in London sewage samples. London: UKHSA. [Accessed: 6 May 2024]. Available from: https://www.gov.uk/government/publications/polio-detection-of-vdpv2-in-london-sewage-samples/immediate-actions-in-response-to-detection-of-vaccine-derived-polio-virus-type-2-vdpv2-in-london-sewage-samples
  12. Iturriza-Gómara M, Megson B, Gray J. Molecular detection and characterization of human enteroviruses directly from clinical samples using RT-PCR and DNA sequencing. J Med Virol. 2006;78(2):243-53.  https://doi.org/10.1002/jmv.20533  PMID: 16372287 
  13. Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol. 2006;44(8):2698-704.  https://doi.org/10.1128/JCM.00542-06  PMID: 16891480 
  14. World Health Organization (WHO). Polio laboratory manual. 4th ed. Geneva: WHO; 2004. WHO/IVB/04.10. Available from: https://iris.who.int/handle/10665/68762
  15. UK Health Security Agency (UKHSA). Cover of vaccination evaluated rapidly (COVER) programme 2022 to 2023: quarterly data. London: UKHSA. [Accessed: 9 May 2024]. Available from: https://www.gov.uk/government/statistics/cover-of-vaccination-evaluated-rapidly-cover-programme-2022-to-2023-quarterly-data
  16. Moran-Gilad J, Mendelson E, Burns CC, Bassal R, Gdalevich M, Sofer D, et al. Field study of fecal excretion as a decision support tool in response to silent reintroduction of wild-type poliovirus 1 into Israel. J Clin Virol. 2015;66:51-5.  https://doi.org/10.1016/j.jcv.2015.03.005  PMID: 25866337 
  17. Kadambari S, Bukasa A, Okike IO, Pebody R, Brown D, Gallimore C, et al. Enterovirus infections in England and Wales, 2000-2011: the impact of increased molecular diagnostics. Clin Microbiol Infect. 2014;20(12):1289-96.  https://doi.org/10.1111/1469-0691.12753  PMID: 25039903 
  18. van der Sanden SMG, Koopmans MPG, van der Avoort HG. Detection of human enteroviruses and parechoviruses as part of the national enterovirus surveillance in the Netherlands, 1996-2011. Eur J Clin Microbiol Infect Dis. 2013;32(12):1525-31.  https://doi.org/10.1007/s10096-013-1906-9  PMID: 23780695 
  19. UK Health Security Agency (UKHSA). Enterovirus: summary of strain characterisation. London: UKHSA; 2023. Available from: https://www.gov.uk/government/publications/enterovirus-strain-characterisation/enterovirus-summary-of-strain-characterisation
  20. Hird TR, Grassly NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog. 2012;8(4):e1002599.  https://doi.org/10.1371/journal.ppat.1002599  PMID: 22532797 
  21. Office for National Statistics (ONS). Ethnic group by age and sex in England and Wales. Newport: ONS. [Accessed: 14 May 2024]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/culturalidentity/ethnicity/datasets/ethnicgroupbyageandsexinenglandandwales
  22. The Greater London Authority (GLA). London demographics map portal. London; HLA. [Accessed: 12 Feb 2025]. Available from: https://mangomap.com/demographics/maps
  23. Public Health England (PHE). Tailoring Immunisation Programmes: Charedi community, north London. London: PHE; 2016. Available from: https://www.gov.uk/government/publications/tailoring-immunisation-programmes-charedi-community-north-london
/content/10.2807/1560-7917.ES.2025.30.16.2500025
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error